Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma Lucia LonghitanoNunzio VicarioDaniele Tibullo Original Article Open access 03 June 2022 Pages: 1 - 20
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma Lucia LonghitanoNunzio VicarioDaniele Tibullo Correction Open access 12 July 2022 Pages: 21 - 21
Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors Chen WeiMengyu WangNing Li Original Article Open access 04 June 2022 Pages: 23 - 37
An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia Natsuki NakagawaYoshiko HashiiKeiichi Ozono Original Article Open access 14 June 2022 Pages: 39 - 53
Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients Maria DavernNoel E. DonlonJoanne Lysaght Original Article Open access 16 June 2022 Pages: 55 - 71
Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer Ding JianyiGan HailiHan Lingfei Original Article Open access 20 June 2022 Pages: 73 - 85
Correction to: Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer Ding JianyiGan HailiHan Lingfei Correction Open access 25 October 2022 Pages: 87 - 89
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study) Renaud DescourtLaurent GreillierChantal Decroisette Original Article 21 June 2022 Pages: 91 - 99
Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint Jie LeiJianfei ZhuXiaoping Wang Original Article 24 June 2022 Pages: 101 - 124
Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer Niannian JiMeijun LongRobert S. Svatek Original Article 24 June 2022 Pages: 125 - 136
Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome Sandra van WilpeShabaz SultanNiven Mehra Original Article Open access 30 June 2022 Pages: 137 - 149
Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model Michelle A. HsuStephanie M. OkamuraMiguel Garcia-Guzman Original Article Open access 01 July 2022 Pages: 151 - 168
The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer Yohei NoseTakuro SaitoHisashi Wada Original Article 01 July 2022 Pages: 169 - 181
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination Ryan M. KahnGovind RagupathiRoisin E. O’Cearbhaill Original Article 02 July 2022 Pages: 183 - 191
TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism Kaikai ZhaoLiyang JiangXiangjiao Meng Original Article Open access 06 July 2022 Pages: 193 - 209
Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis Liwei LvYuchen WuYuanbo Liu Original Article 07 July 2022 Pages: 211 - 221
Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis Guangyi JiangYu Yang NgJianqing Zhu Original Article 09 July 2022 Pages: 223 - 234
Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays Ning LouCuiling ZhengXiaohong Han Original Article 13 July 2022 Pages: 235 - 247
Hematologic malignancies following immune checkpoint inhibition for solid tumors Mick J. M. van EijsLotte E. van der WagenKarijn P. M. Suijkerbuijk Research Report Open access 13 June 2022 Pages: 249 - 255
Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19 Sara FiorettiCourtney A. MatsonNevil J. Singh Research Report 26 June 2022 Pages: 257 - 264
High salt diet does not impact the development of acute myeloid leukemia in mice Mathangi JanakiramanNatallia SaleiGurumoorthy Krishnamoorthy Research Report Open access 08 July 2022 Pages: 265 - 273
The impact of body mass index on overall survival in patients with cancer receiving immunotherapy: a dose-response meta-analysis Oliver John KennedyMarianne Therese Neary Letter to the Editors 11 June 2022 Pages: 275 - 276